Intrapatient variability of tacrolimus trough level may be not the cause, but an indirect parameter of comorbidities: Editorial on "Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation"

他克莫司谷浓度的患者内变异性可能并非病因，而是合并症的间接指标：关于“降低CKD风险的最佳他克莫司水平以及患者内变异性对肝移植后CKD和ESRD发展的影响”的社论